Log in

DIVISLAB Divi's Laboratories Limited NSE · India

Divi's Laboratories (DIVISLAB) news

Divi's Laboratories Limited is a public biotech or pharmaceutical company listed on NSE under the ticker DIVISLAB, recorded under India. The directory classifies it as Biopharma / pharmaceutical profile checked. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Divi's Laboratories news

We have not published a story on Divi's Laboratories yet. When there is news, it will appear here.

Questions about Divi's Laboratories

What is the ticker symbol of Divi's Laboratories?

Divi's Laboratories Limited trades under the ticker DIVISLAB on NSE.

Where is Divi's Laboratories listed?

Divi's Laboratories Limited is listed on NSE. Our directory also records these other listings: BSE:DIVISLAB.

Which country or territory is Divi's Laboratories listed under?

Our directory records Divi's Laboratories Limited under India.

What does Divi's Laboratories do?

Our directory classifies Divi's Laboratories Limited as: Biopharma / pharmaceutical profile checked. This is a directory classification, not a description of the pipeline.

What is the ISIN of Divi's Laboratories?

The ISIN recorded for Divi's Laboratories Limited is INE361B01024.

Does aibio.space cover Divi's Laboratories?

aibio.space lists Divi's Laboratories Limited among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Divi's Laboratories?

Companies in our directory listed in the same country and business area as Divi's Laboratories: Ind-Swift Laboratories, Gennex Laboratories, Sandu Pharmaceuticals, Zenith Healthcare, Amrutanjan Health Care, Lyka Labs.

Investor discussion: Divi's Laboratories

Members talk about Divi's Laboratories (DIVISLAB). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open NSE:DIVISLAB on TradingView.

Listing details

Divi's Laboratories Limited is a public biotech or pharmaceutical company listed on NSE under the ticker DIVISLAB, recorded under India. The directory classifies it as Biopharma / pharmaceutical profile checked. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Divi's Laboratories Limited
Ticker
DIVISLAB
Listing
NSE
Country or territory
India
Business scope
Biopharma / pharmaceutical profile checked
ISIN
INE361B01024
Other listed symbols
BSE:DIVISLAB
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.